RFA for GIM Treatment
Launched by KING CHULALONGKORN MEMORIAL HOSPITAL · Apr 14, 2020
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
Gastric intestinal metaplasia (GIM) is a pre-malignant lesion. Currently, there is no standard treatment for this condition, thus the patients with GIM need surveillance endoscopy every 1-3 years, regarding to the severity and extension of lesion. However, the protocol for GIM surveillance is uncertain and need high cost.
Radiofrequency ablation (RFA) is used for Barrett's esophagus (BE; pre-malignant lesion of esophageal adenoCA) treatment as a standard treatment. The investigators hypothesized that RFA may effective in GIM treatment.
The investigators will random GIM participants to hav...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • More than 18 years of age
- • Previous diagnose of extensive or incomplete GIM
- Exclusion Criteria:
- • No GIM at first endoscopy
- • Previous gastric surgery
- • Coagulopathy
- • Pregnancy or lactation
- • Unable to perform appropriate peri-procedural cessation of antiplatelet/antithrombotic therapy
- • Unable to sign the consent
About King Chulalongkorn Memorial Hospital
King Chulalongkorn Memorial Hospital, a leading medical institution in Thailand, is renowned for its commitment to advancing healthcare through innovative research and clinical trials. Affiliated with Chulalongkorn University, the hospital integrates cutting-edge medical practices with a robust academic framework, fostering an environment conducive to pioneering clinical studies. With a focus on improving patient outcomes and contributing to global medical knowledge, the hospital engages in a diverse range of clinical trials across various therapeutic areas, ensuring adherence to the highest ethical standards and regulatory guidelines. Through collaboration with healthcare professionals and researchers, King Chulalongkorn Memorial Hospital aims to enhance the quality of care while driving forward the frontiers of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pathum Wan, Bangkok, Thailand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials